Key facts
- This page summarizes Chairman Michael J. Farrell's Form 4 filing for RESMED INC (RMD).
- 3 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 13 Nov 2026, 15:15.
Chairman Michael J. Farrell - 11 Nov 2026 Form 4 Insider Report for RESMED INC (RMD)
- Reporting relationship
- Chairman and CEO, Director
- Issuer ticker
- RMD
- Reported as of
- 11 Nov 2026
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 13 Nov 2026, 15:15:13 UTC
- Prior SEC filing
- 12 Nov 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Michael J. Farrell, Chairman and CEO
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Filing notes and source
Key filing fact
Chairman Michael J. Farrell filed Form 4 for RESMED INC (RMD) on 13 Nov 2026.
Change
- Previous filing in this sequence was filed on 12 Nov 2026.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001485164
Primary reporting owner
Farrell Michael J.
- Relationship
- Chairman and CEO, Director
- Address
- RESMED INC., 9001 SPECTRUM CENTER BLVD, SAN DIEGO
- Signature
- /s/ Michael J. Farrell, Chairman and CEO
- Signature date
- 13 Nov 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
RMD
transaction
ResMed Common Stock
Tax liability
- Transaction value
- Shares
- -3,466
- Change %
- -0.72%
- Price
- $234.11*
- Shares after
- 476,419
- Date
- 11 Nov 2026
- Ownership
- Direct
- Footnotes
- F1
RMD
transaction
ResMed Common Stock
Tax liability
- Transaction value
- Shares
- -2,210
- Change %
- -0.46%
- Price
- $234.11*
- Shares after
- 474,209
- Date
- 11 Nov 2026
- Ownership
- Direct
- Footnotes
- F2
RMD
transaction
ResMed Common Stock
Tax liability
- Transaction value
- Shares
- -2,436
- Change %
- -0.51%
- Price
- $234.11*
- Shares after
- 471,774
- Date
- 11 Nov 2026
- Ownership
- Direct
- Footnotes
- F3, F4
RMD
holding
ResMed Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 2,090
- Date
- 11 Nov 2026
- Ownership
- Lisette and Michael Farrell Family Trust
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 4 footnotes
Footnote F1
Disposition to issuer for tax withholding on vesting of Restricted Stock Units granted on 11/16/2023.
Footnote F2
Disposition to issuer for tax withholding on vesting of Restricted Stock Units granted on 11/20/2024.
Footnote F3
Disposition to issuer for tax withholding on vesting of Restricted Stock Units granted on 11/20/2025.
Footnote F4
Includes 82.2684 shares of Resmed stock purchased on Oct 30, 2026 through the Resmed Employee Stock Purchase Plan.